Question 1

What is Moxifloxacin?

Accepted Answer

Moxifloxacin is a Other.

Question 2

How often does Moxifloxacin appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Moxifloxacin first tracked by Ergen?

Accepted Answer

First tracked on Feb 12, 2026.

Question 4

When was Moxifloxacin last mentioned in news?

Accepted Answer

Last active on Feb 13, 2026.

Question 5

What is Moxifloxacin's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Moxifloxacin in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Moxifloxacin?

Accepted Answer

India TB Regimen Cost-Effective Study (Feb 12, 2026, 6 articles).

Question 8

How did the "India TB Regimen Cost-Effective Study" event impact Moxifloxacin?

Accepted Answer

Moxifloxacin is a component of the BPaLM regimen, which was found to be highly cost-effective for treating multidrug-resistant and rifampicin-resistant tuberculosis.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.